Clinical trial
Effects of Vernakalant and Flecainide on Atrial Contractility in Patients With Atrial Fibrillation
NCT01646281 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Vernakalant and Flecainide on Atrial Contractility in Patients With Atrial Fibrillation
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.